Page last updated: 2024-11-03

pyrimethamine and Polycystic Kidney, Autosomal Dominant

pyrimethamine has been researched along with Polycystic Kidney, Autosomal Dominant in 1 studies

Maloprim: contains above 2 cpds

Polycystic Kidney, Autosomal Dominant: Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function.

Research Excerpts

ExcerptRelevanceReference
"Treatment with pyrimethamine decreases cell proliferation in human ADPKD cells and blocks renal cyst formation in an adult and a neonatal PKD mouse model."5.37Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. ( Frank, DA; Haque, N; Humphreys, BD; Nelson, EA; Takakura, A; Zandi-Nejad, K; Zhou, J, 2011)
"Treatment with pyrimethamine decreases cell proliferation in human ADPKD cells and blocks renal cyst formation in an adult and a neonatal PKD mouse model."1.37Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. ( Frank, DA; Haque, N; Humphreys, BD; Nelson, EA; Takakura, A; Zandi-Nejad, K; Zhou, J, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takakura, A1
Nelson, EA1
Haque, N1
Humphreys, BD1
Zandi-Nejad, K1
Frank, DA1
Zhou, J1

Other Studies

1 other study available for pyrimethamine and Polycystic Kidney, Autosomal Dominant

ArticleYear
Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways.
    Human molecular genetics, 2011, Nov-01, Volume: 20, Issue:21

    Topics: Adult; Aminosalicylic Acids; Animals; Animals, Newborn; Benzenesulfonates; Cell Line; Cysts; Disease

2011